Silence Therapeutics (SLN) Retained Earnings: 2019-2025
Historic Retained Earnings for Silence Therapeutics (SLN) over the last 5 years, with Sep 2025 value amounting to -$550.8 million.
- Silence Therapeutics' Retained Earnings fell 22.29% to -$550.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$550.8 million, marking a year-over-year decrease of 22.29%. This contributed to the annual value of -$474.0 million for FY2024, which is 9.76% down from last year.
- Latest data reveals that Silence Therapeutics reported Retained Earnings of -$550.8 million as of Q3 2025, which was down 3.96% from -$529.8 million recorded in Q2 2025.
- Silence Therapeutics' 5-year Retained Earnings high stood at -$284.7 million for Q2 2021, and its period low was -$550.8 million during Q3 2025.
- Moreover, its 3-year median value for Retained Earnings was -$431.9 million (2023), whereas its average is -$435.0 million.
- Its Retained Earnings has fluctuated over the past 5 years, first plummeted by 40.74% in 2021, then rose by 0.06% in 2022.
- Over the past 5 years, Silence Therapeutics' Retained Earnings (Quarterly) stood at -$300.6 million in 2021, then decreased by 2.74% to -$308.8 million in 2022, then slumped by 39.87% to -$431.9 million in 2023, then decreased by 9.76% to -$474.0 million in 2024, then fell by 22.29% to -$550.8 million in 2025.
- Its Retained Earnings was -$550.8 million in Q3 2025, compared to -$529.8 million in Q2 2025 and -$502.5 million in Q1 2025.